Company Health Advance Inc. Other OTC
Equities
HADV
US42225L2034
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Larry McLachlin
CEO | Chief Executive Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Larry McLachlin
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 185,947,500 | 167,632,482 ( 90.15 %) | 0 | 90.15 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |